innoscripta SE (ETR:1INN)
Germany · Delayed Price · Currency is EUR | Market Cap | 892.00M |
| Revenue (ttm) | 103.41M +59.8% |
| Net Income | 42.61M +69.8% |
| EPS | 4.26 +69.8% |
| Shares Out | 10.00M |
| PE Ratio | 20.93 |
| Forward PE | 15.67 |
| Dividend | 4.00 (4.48%) |
| Ex-Dividend Date | Apr 22, 2026 |
| Volume | 6,354 |
| Open | 90.00 |
| Previous Close | 89.20 |
| Day's Range | 88.50 - 90.70 |
| 52-Week Range | 61.10 - 137.00 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 212.14 (+138.63%) |
| Earnings Date | Aug 20, 2026 |
About innoscripta SE
innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in Germany and France. It offers solutions for research and development documentation, such as human resources, task management, organization, project management, and time tracking. It serves the additive manufacturing/3D printing; aerospace engineering; automotive; biotechnology; business consulting and technical services; chemical; construction; electrical engineering; energy; environmental technology and ... [Read more]
Financial Performance
In 2025, innoscripta SE's revenue was 103.41 million, an increase of 59.82% compared to the previous year's 64.71 million. Earnings were 42.61 million, an increase of 69.82%.
Financial StatementsNews
innoscripta SE Quarterly report: Q1 2026
innoscripta SE has published its Q1 2026 quarterly earnings report on May 26, 2026.
innoscripta SE Slides: Q1 2026
innoscripta SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 26, 2026.
innoscripta SE Annual report: Q4 2025
innoscripta SE has published its Q4 2025 annual report on March 20, 2026.
innoscripta SE Annual report: Q4 2025
innoscripta SE has published its Q4 2025 annual report on March 20, 2026.
innoscripta SE Earnings Call Transcript: Q4 2025
Revenue and EBIT surged nearly 60% year-over-year, driven by enterprise client wins and product innovation. Management expects continued high growth and margins, supported by regulatory tailwinds and international expansion, with a focus on shareholder returns.
innoscripta SE Earnings release: Q4 2025
innoscripta SE released its Q4 2025 earnings on February 3, 2026, summarizing the period's financial results.
innoscripta SE Slides: Q4 2025
innoscripta SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 3, 2026.
innoscripta SE Quarterly report: Q3 2025
innoscripta SE has published its Q3 2025 quarterly earnings report on November 3, 2025.
innoscripta SE Slides: Q3 2025
innoscripta SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 3, 2025.
innoscripta SE Earnings Call Transcript: Q2 2025
Half-year revenue surged 90% year-over-year to EUR 44.1 million, with EBIT more than doubling and margins reaching 58%. Strong customer growth, low churn, and regulatory changes are expected to further boost revenue, while cash flow and profitability remain robust.
innoscripta SE Quarterly report: Q2 2025
innoscripta SE has published its Q2 2025 quarterly earnings report on August 21, 2025.
innoscripta SE Slides: Q2 2025
innoscripta SE has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 21, 2025.